Range Capital Acquisition Stock (NASDAQ: RANGU)

Latest news for Range Capital Acquisition (NASDAQ:RANGU) Stock

Range Capital Acquisition Corp is a blank check company.

Range Capital Acquisition Corp

LVTX

Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times

Entertainment

News

General

Macy's Inks New 10-Year Rights Deal With NBCUniversal For Macy's Thanksgiving Day Parade And Macy's 4th of July Fireworks On NBC, Peacock And Telemundo

Baird analyst Shrenik Kothari maintains CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Outperform and raises the price target from $455 to $465.

Price Target

Analyst Ratings

CYBR

Baird Maintains Outperform on CyberArk Software, Raises Price Target to $465

DRVN

Driven Brands Sees FY25 Revenues Of $2.05B-$2.15B Vs. $2.53B Estimate, Sees Adjusted EPS Of $1.15-$1.25 Vs. $1.24 Estimate

HC Wainwright &amp; Co. analyst Emily Bodnar maintains MiNK Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INKT#NASDAQ">INKT</a>) with a Buy and raises the price target from $9 to $35.

INKT

HC Wainwright & Co. Maintains Buy on MiNK Therapeutics, Raises Price Target to $35

ChampionX Agrees To Sell All Of Its Equity Interests In US Synthetic Corporation To LongRange Capital LP

Contracts

Embraer-Empresa Brasileira De Aeronautica

ANA Holdings Inc. Orders 15 E190-E2s Aircraft From Embraer

Baird analyst Eric Coldwell maintains Owens &amp; Minor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) with a Neutral and lowers the price target from $14 to $10.

Baird Maintains Neutral on Owens & Minor, Lowers Price Target to $10

Bicycle Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCYC#NASDAQ">BCYC</a>) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.87) by 13.79 percent. This is a 35.34 percent increase over losses of $(1.16) per share from the same period last year.

Earnings

BCYC

Bicycle Therapeutics Q4 2024 GAAP EPS $(0.75) Beats $(0.87) Estimate, Cash And Cash Equivalents Of $879.5M As Of December 31, 2024, Expected To Provide Financial Runway Into 2H 2027

Baird analyst David Tarantino maintains Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Outperform and lowers the price target from $545 to $510.

Baird Maintains Outperform on Domino's Pizza, Lowers Price Target to $510

HC Wainwright &amp; Co. analyst Edward White reiterates 60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) from Neutral to Neutral.

Reiteration

SXTP

HC Wainwright & Co. Reiterates Neutral on 60 Degreesto Neutral

Driven Brands Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRVN#NASDAQ">DRVN</a>) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.18 by 66.67 percent. This is a 57.89 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $564.117 million which missed the analyst consensus estimate of $572.161 million by 1.41 percent. This is a 1.89 percent increase over sales of $553.677 million the same period last year.

Earnings Beats

Earnings Misses

Driven Brands Hldgs Q4 2024 Adj. EPS $0.30 Beats $0.18 Estimate, Sales $564.117M Miss $572.161M Estimate

ELAN

Elanco Inks Agreement With South Dakota-Based Medgene To Commercialize Highly Pathogenic Avian Influenza Vaccine In Dairy Cattle

Beam Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.18) by 7.63 percent. This is a 163.01 percent decrease over earnings of $1.73 per share from the same period last year.

BEAM

Beam Therapeutics Q4 2024 GAAP EPS $(1.09) Beats $(1.18) Estimate, Ended Fourth Quarter 2024 with $850.7M in Cash, Cash Equivalents and Marketable Securities; Cash Runway Expected to Support Operating Plans into 2027

Biotech

ProMIS Neurosciences Doses First Patients In Its Phase 1b PRECISE-AD Trial Of PMN310 In Alzheimer's Disease

Baird analyst Michael Bellisario maintains Choice Hotels Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHH#NYSE">CHH</a>) with a Outperform and raises the price target from $145 to $160.

Baird Maintains Outperform on Choice Hotels Intl, Raises Price Target to $160

Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in exchange for a high-single digit royalty on worldwide sales of D-Fi. The syndicate includes existing Castle Creek investors Paragon Biosciences and Valor Equity Partners and new investor XOMA Royalty Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>).

Health Care

Financing

LGND

XOMA

Ligand Pharmaceuticals Closed A Royalty Financing Agreement With Castle Creek Biosciences, Inc. To Support The Phase 3 Study Of D-Fi (FCX-007), Castle Creek's Lead Candidate, In Patients With Dystrophic Epidermolysis Bullosa

E-commerce player Amazon.com Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) quarterly revenue surpassed retail giant Walmart Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) sales in the fourth quarter for the first time since 2000. Jeff Bezos said in 2018 that every overnight success takes at least 10 years, but this particular milestone took 25 years.
What Happened: Both <a href="https://www.benzinga.com/25/02/43545590/amazoncom-q4-earnings-highlights-revenue-beat-eps-beat-most-successful-holiday-shopping-season-in-company-history">Amazon</a> and <a href="https://www.benzinga.com/news/earnings/25/02/43846469/walmart-q4-earnings-shine-but-soft-fy26-outlook-disappoints-street">Walmart</a> reported strong fourth-quarter results, exceeding analyst expectations. Amazon&#8217;s net sales reached $187.8 billion with $1.86 EPS, while Walmart&#8217;s sales hit $180.55 billion with $0.66 adjusted EPS, both demonstrating growth and outperforming consensus estimates. 
Charlie Bilello, the chief market strategist at Creative Planning highlighted in an X post how Amazon's revenue has gradually grown over the years.
From making 77 times lower in quarterly sales as compared to the retail giant Walmart in the year 2000 to exceeding the former in terms of revenue earned in the fourth quarter of fiscal year 2025, Amazon has had a long journey.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">25 yrs ago: Walmart revenue 77x larger than Amazon 15 yrs ago: Walmart revenue 12x larger than Amazon 10 yrs ago: Walmart revenue 5x larger than Amazon 5 yrs ago: Walmart revenue 2x larger than Amazon Today: Amazon revenue &gt; Walmart revenue<a href="https://twitter.com/search?q=%24AMZN&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$AMZN</a> <a href="https://twitter.com/search?q=%24WMT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$WMT</a> <a href="https://t.co/PiDKnmCEu5">pic.twitter.com/PiDKnmCEu5</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1893734565048459566?ref_src=twsrc%5Etfw">February 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/02/43933428/dominos-pizza-serves-consistent-market-share-gains-since-2015-despite-q4-earnings-miss-aims-for-3-same-store-sales-growth-to-capture-additional-share">Domino&#8217;s Pizza Sees 1% QSR Market Share Increase Despite Q4 Earnings Miss: &#8216;Consistent With Our Average Annual Share Growth&#8217;</a>
Why It Matters: &#8220;All overnight success takes about 10 years,&#8221; Bezos <a href="https://www.benzinga.com/startups/24/10/41255752/jeff-bezos-says-all-overnight-success-takes-10-years-amazon-didnt-turn-a-profit-for-almost-a-decade">said</a> in a 2018 CNBC interview. 
Bezos attributed Amazon&#8217;s success to a long-term, forward-thinking approach, recognizing that current results reflect decisions made in the years prior. According to him, <a href="https://www.benzinga.com/startups/24/10/41255752/jeff-bezos-says-all-overnight-success-takes-10-years-amazon-didnt-turn-a-profit-for-almost-a-decade">prioritizing innovation</a> and calculated risks over short-term profits, led to services like Prime and AWS.
Despite early financial losses, Bezos&#8217; commitment to &#8220;high-quality failures&#8221; and continuous experimentation paved the way for Amazon&#8217;s current dominance across multiple sectors.
According to the in-depth fundamental analysis by <a href="https://www.benzinga.com/insights/news/25/02/43914135/in-depth-analysis-amazon-com-versus-competitors-in-broadline-retail-industry">Benzinga Insights</a>, Amazon.com exhibits higher valuations than its broadline retail industry peers. 
<ul>
<li>Its price-to-earnings was at 39.16, 1.6x above the industry norm, price-to-book was at 8.03 relative to the industry average by 1.32x, and price-to-sales of 3.64 was 2.09x the industry average.</li>
</ul>
<ul>
<li>Higher P/E, P/B, and P/S ratios significantly exceed industry averages, though its ROE is slightly above average, indicating efficient equity use.</li>
</ul>
<ul>
<li>On the other hand, its EBITDA, gross profit, and revenue growth suggest strong financial performance and growth potential relative to industry competitors.</li>
</ul>
Price Action: Amazon fell 0.24% in premarket on Tuesday, contrasting with a 0.28% fall in the Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which tracks the Nasdaq 100 index.
AMZN remains lower by 3.41% on a year-to-date basis and 1.74% over a year.
<a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">Benzinga tracks 43 analysts</a> with an average price target of $264.05 for the stock, reflecting a &#8220;buy&#8221; rating. Estimates range widely from $207 to $306. Recent ratings from Loop Capital, Citigroup, and Maxim Group average $279.33, suggesting a potential 32.07% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AMZN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="383" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR-1024x383.png" alt="" class="wp-image-797284" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR-1024x383.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR-768x287.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25065251/Amazon-ANR.png 1068w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43932776/mark-cuban-slams-fd-up-healthcare-system-blames-insurance-designed-deductibles-for-patient-bankruptcy">Mark Cuban Calls Deductibles &#8216;The Biggest Problem&#8217; in Healthcare: &#8216;System…Needs To Be Redesigned&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Markets

AMZN

Jeff Bezos Once Said 'Overnight Success' Takes 10 Years. It Took Amazon 25 Years To Surpass Walmart's Revenue

Travelzoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZOO#NASDAQ">TZOO</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.30 by 13.33 percent. This is a 8.33 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $20.68 million which missed the analyst consensus estimate of $22.06 million by 6.26 percent. This is a 2.23 percent decrease over sales of $21.15 million the same period last year.

TZOO

Travelzoo Q4 EPS $0.26 Misses $0.30 Estimate, Sales $20.68M Miss $22.06M Estimate

Management

Driven Brands Announces COO Daniel Rivera Will Become President And CEO On May 9

Offerings

Press Releases

Range Capital Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

Range Capital Acquisition Corp. Announces Closing of $100 Million Initial Public Offering

Range Capital Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing January 13, 2025

RANG

RANGU

Range Capital Acquisition

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

The units are expected to commence trading on December 20, 2024 on the Nasdaq Global Market under the symbol "RANGU."

Comments

Range Capital Acquisition

News

Latest news for Range Capital Acquisition (NASDAQ:RANGU) Stock

Friday, December 20, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga